Cargando…

Vancomycin-Induced Hemolytic Anemia

Drug-induced hemolytic anemia is rare and can occur either by an immune-mediated mechanism or a non-immune-mediated mechanism. The drugs most frequently associated with immune-mediated hemolysis are penicillins and cephalosporins. It is usually difficult to distinguish drug-induced hemolysis from ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Fakeha, Cheema, Ahmad, Kamran, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195073/
https://www.ncbi.nlm.nih.gov/pubmed/37216133
http://dx.doi.org/10.7759/cureus.39191
_version_ 1785044148378664960
author Siddiqui, Fakeha
Cheema, Ahmad
Kamran, Amir
author_facet Siddiqui, Fakeha
Cheema, Ahmad
Kamran, Amir
author_sort Siddiqui, Fakeha
collection PubMed
description Drug-induced hemolytic anemia is rare and can occur either by an immune-mediated mechanism or a non-immune-mediated mechanism. The drugs most frequently associated with immune-mediated hemolysis are penicillins and cephalosporins. It is usually difficult to distinguish drug-induced hemolysis from other more common causes of hemolysis; therefore, a high index of clinical suspicion is required to make the diagnosis. In this case report, we present a case of vancomycin-induced immune hemolytic anemia in a 75-year-old patient who developed hemolytic anemia after starting vancomycin for joint infection. Hematological parameters improved after the discontinuation of vancomycin. Mechanism and management of drug-induced immune hemolytic anemia are also reviewed in this report. 
format Online
Article
Text
id pubmed-10195073
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-101950732023-05-19 Vancomycin-Induced Hemolytic Anemia Siddiqui, Fakeha Cheema, Ahmad Kamran, Amir Cureus Internal Medicine Drug-induced hemolytic anemia is rare and can occur either by an immune-mediated mechanism or a non-immune-mediated mechanism. The drugs most frequently associated with immune-mediated hemolysis are penicillins and cephalosporins. It is usually difficult to distinguish drug-induced hemolysis from other more common causes of hemolysis; therefore, a high index of clinical suspicion is required to make the diagnosis. In this case report, we present a case of vancomycin-induced immune hemolytic anemia in a 75-year-old patient who developed hemolytic anemia after starting vancomycin for joint infection. Hematological parameters improved after the discontinuation of vancomycin. Mechanism and management of drug-induced immune hemolytic anemia are also reviewed in this report.  Cureus 2023-05-18 /pmc/articles/PMC10195073/ /pubmed/37216133 http://dx.doi.org/10.7759/cureus.39191 Text en Copyright © 2023, Siddiqui et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Siddiqui, Fakeha
Cheema, Ahmad
Kamran, Amir
Vancomycin-Induced Hemolytic Anemia
title Vancomycin-Induced Hemolytic Anemia
title_full Vancomycin-Induced Hemolytic Anemia
title_fullStr Vancomycin-Induced Hemolytic Anemia
title_full_unstemmed Vancomycin-Induced Hemolytic Anemia
title_short Vancomycin-Induced Hemolytic Anemia
title_sort vancomycin-induced hemolytic anemia
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195073/
https://www.ncbi.nlm.nih.gov/pubmed/37216133
http://dx.doi.org/10.7759/cureus.39191
work_keys_str_mv AT siddiquifakeha vancomycininducedhemolyticanemia
AT cheemaahmad vancomycininducedhemolyticanemia
AT kamranamir vancomycininducedhemolyticanemia